Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Antineoplastic drugs

Neutropenia and no response: 15 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mastrangelo S, et al. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers 14: No. 20, 21 Oct 2022. Available from: URL: http://doi.org/10.3390/cancers14205170 Mastrangelo S, et al. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers 14: No. 20, 21 Oct 2022. Available from: URL: http://​doi.​org/​10.​3390/​cancers14205170
Metadaten
Titel
Antineoplastic drugs
Neutropenia and no response: 15 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41712-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Azd-1222

Case report

Paclitaxel

Case report

Zolpidem

Case report

Flecainide